← Leaderboards
Lizi Wu
University Of Florida
$6,524,555
Attributed
$6,524,555
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $767.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,524,555 · 5
By mechanism
R01$5,939,879 · 3
R21$349,271 · 1
P30$235,405 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionPathway InteractionsMalignant NeoplasmsTherapeutic TargetTumorigenesisMolecularBiologyNovel Therapeutic InterventionInsightOncogenesIn VivoGenetic TranscriptionGrowthCreb1 GeneMouse ModelMutationEventTransgenic MiceTumorIn VitroProgramsMediatingGenesMetabolism
Grant awards (24)
Mechanisms of Oncogenesis Research Program$79,843
P30 · FY2025 · CA · contact PI
Mechanisms of Oncogenesis Research Program$77,781
P30 · FY2024 · CA · contact PI
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland$354,322
R01 · FY2023 · DE · contact PI
Aberrant CRTC activation as a unique vulnerability of lung cancer with LKB1 inactivation$335,396
R01 · FY2023 · CA · contact PI
Mechanisms of Oncogenesis Research Program$77,781
P30 · FY2023 · CA · contact PI
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland$351,487
R01 · FY2022 · DE · contact PI
Aberrant CRTC activation as a unique vulnerability of lung cancer with LKB1 inactivation$335,704
R01 · FY2022 · CA · contact PI
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland$355,687
R01 · FY2021 · DE · contact PI
Aberrant CRTC activation as a unique vulnerability of lung cancer with LKB1 inactivation$342,855
R01 · FY2021 · CA · contact PI
Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland$356,278
R01 · FY2020 · DE · contact PI
Aberrant CRTC activation as a unique vulnerability of lung cancer with LKB1 inactivation$343,140
R01 · FY2020 · CA · contact PI
Aberrant CRTC activation as a unique vulnerability of lung cancer with LKB1 inactivation$343,411
R01 · FY2019 · CA · contact PI
Signaling and targeting of CRTC1-MAML2 fusion oncoprotein in salivary gland tumor$368,314
R01 · FY2017 · DE · contact PI
Signaling and targeting of CRTC1-MAML2 fusion oncoprotein in salivary gland tumor$370,204
R01 · FY2016 · DE · contact PI
A novel noncoding RNA and human lung cancers with inactivated LKB1 signaling$158,206
R21 · FY2016 · CA · contact PI
Signaling and targeting of CRTC1-MAML2 fusion oncoprotein in salivary gland tumor$376,529
R01 · FY2015 · DE · contact PI
A novel noncoding RNA and human lung cancers with inactivated LKB1 signaling$191,065
R21 · FY2015 · CA · contact PI
Signaling and targeting of CRTC1-MAML2 fusion oncoprotein in salivary gland tumor$377,458
R01 · FY2014 · DE · contact PI
Transformation of Epithelial Cell by E6 Oncogene$205,236
R01 · FY2007 · CA · contact PI
Transformation of Epithelial Cell by E6 Oncogene$160,211
R01 · FY2006 · CA · contact PI
Transformation of Epithelial Cell by E6 Oncogene$115,772
R01 · FY2006 · CA · contact PI
Transformation of Epithelial Cell by E6 Oncogene$282,625
R01 · FY2005 · CA
Transformation of Epithelial Cell by E6 Oncogene$282,625
R01 · FY2004 · CA
Transformation of Epithelial Cell by E6 Oncogene$282,625
R01 · FY2003 · CA